Health care providers say that hesitation and outright resistance to vaccines have become disturbingly common even in ...

Moderna MRNA announced fourth-quarter 2024 results. Though earnings and sales beat estimates, both metrics declined ...

In his first address to staffers at HHS since becoming secretary of the department on Feb. 13, Robert F. Kennedy Jr. Tuesday ...

Moderna (MRNA) closed down more than -7% to lead losers in the S&P 500 as vaccine makers tumbled on expectations that ... Holdings Inc (PYPL), Pentair PLC (PNR), PepsiCo Inc (PEP), Pfizer Inc (PFE), ...

Thousands of U.S. health agency employees were terminated and told it was for poor performance, though they'd received strong ...

We can refer to full-year 2019 revenue of about $51 billion and the company's comments about potential revenue of more than ...

Penmenvy, which protects against five common types of disease-causing bacteria, is cleared for use in people aged 10 through ...

Senate committee members heard arguments on a bill that would place a 10-year pause on administering mRNA vaccines in Idaho ...

EPS estimates but beats revenue expectations. Barclays downgrades stock, citing COVID demand decline and RSV uptake ...

Penn researchers are developing new treatments using mRNA technology to combat a range of diseases, namely celiac disease ...

Scientists have developed a lipid nanoparticle system capable of delivering messenger RNA (mRNA) to the brain via intravenous injection, a challenge that has long been limited by the protective nature ...

Vermont has the second lowest state fatality rate in the US (145.3 per 100K; Hawaii 112.6/100K). Mississippi (461.9/100K) and ...